
Loading, please wait...

Loading, please wait...

Working memory deficits are prevalent among individuals with mood disorders. These impairments often hinder daily activities and long-term recovery. Researchers have long suspected that serotonin and working memory share a complex relationship, particularly within the frontal cortex. A recent multi-cohort study used positron emission tomography (PET) brain imaging to examine these features. The study focused on both healthy individuals and patients to map neurobiological associations.
In this comprehensive analysis, the research team evaluated various 5-HT components. These included the 5-HT1B, 5-HT2A, and 5-HT4 receptors, alongside the serotonin transporter (5-HTT). Notably, the results showed no significant association between serotonin and working memory performance in healthy individuals. This suggests that in a typical physiological state, these specific receptor levels may not be the primary drivers of cognitive efficiency.
However, the findings were starkly different for patients diagnosed with mood disorders. Specifically, the study observed a significant positive association between 5-HT4 receptor binding and memory performance. This interaction effect highlights that pathologically altered signaling might be a contributing factor to cognitive impairment. Consequently, these findings suggest that targeting the 5-HT4 receptor system could be a viable therapeutic strategy for addressing cognitive deficits in clinical populations.
The discovery that 5-HT4 receptor levels correlate with memory in patients points toward a unique neurobiological mapping in disease states. This association might arise through downstream signaling pathways. Furthermore, it may involve interactions with other neurotransmitter systems like dopamine. Understanding these differences allows clinicians to better appreciate the heterogeneous nature of mood disorders. Therefore, these insights support the potential for personalized cognitive interventions in psychiatric care.
The study identified the 5-HT4 receptor as having a significant positive association with working memory performance in patients with mood disorders. Other markers like 5-HT1B and 5-HT2A did not show similar associations.
No, the research found no significant link between any of the studied serotonin receptors and working memory in healthy participants. This indicates the association may be specific to pathologically altered states.
The frontal cortex was chosen as the primary region of interest because it is critical for executive functions and working memory. PET imaging in this area allows researchers to quantify receptor binding directly related to cognitive tasks.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Dam VH et al. Serotonin and working memory in mood disorder and healthy states: multi-cohort positron emission tomography study. BJPsych Open. 2026 May 25. doi: 10.1192/bjo.2026.11045. PMID: 42179183.
Murphy SE et al. Translating the promise of 5HT4 receptor agonists for the treatment of depression. Psychological Medicine. 2020;50(11):1-10.
Knudsen GM et al. Serotonin 4 receptor brain binding in major depressive disorder and association with memory dysfunction. JAMA Psychiatry. 2023;80(4):352-360.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


New PET imaging research identifies a significant link between the 5-HT4 receptor and working memory performance specifically in patients with mood disorder...
5 months ago

Union Minister Pratap Jadhav highlights the pivotal role of pharmacists in fighting antibiotic misuse and antimicrobial resistance. By championing rational medicine use, patient counseling, and curriculum modernization, community pharmacists stand as vital guardians of public health across India.
Today

Delhi is undergoing a major healthcare overhaul with enhanced Ayushman Bharat insurance up to ₹10 lakh, increased MBBS and PG medical training seats, expanded primary network mandirs, new tertiary neuro-ICUs, and public-private reproductive technology initiatives to build a resilient, preventative healthcare model.
Today

A landmark NIAS study reveals that regional airshed interventions can slash northern India's fine particulate levels by up to 60%. Discover the profound clinical implications of targeted emission curbs on cardiopulmonary health, chronic respiratory diseases, and population-level preventative strategies.
Today

Non-union fractures occur in 2-5% of cases, causing significant disability and cost. Conservative modalities such as LIPUS, PEMF, and focused ESWT offer non-surgical healing options for defects up to 5-10 mm when adequate mechanical stability exists without infection.
Today

A Brazilian birth cohort reveals significant sex-specific associations between preterm birth and adolescent adiposity, underscoring the urgent need for targeted long-term cardiometabolic surveillance and tailored clinical monitoring.
Today